Analyst firms · Robert W. Baird · AGEN
Robert W. Baird AGEN price target and rating history
Agenus Inc. (AGEN) · Health Care
Robert W. Baird rates Agenus Inc. (AGEN) Neutral with a $8 price target, as of its latest action on Jul 19, 2024. It has published 3 rating actions on AGEN since June 2023, including 0 upgrades and 1 downgrade. Across 3 firms with a AGEN price target in the last 12 months, the median target is $30.
- Current rating
- Neutral
- Price target
- $8
- Median target, all firms
- $30
- Actions on AGEN
- 3
Robert W. Baird price target on AGEN
Every Robert W. Baird rating on AGEN
- Jul 19, 2024
- Jun 6, 2023
- Jun 6, 2023
How other firms rate AGEN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Rodman & Renshaw | Buy | $19 | Sep 28, 2026 |
| Chardan Capital Markets | Buy | $40 | Sep 18, 2026 |
| H.C. Wainwright | Buy | $30 | Jul 13, 2026 |
Questions about Robert W. Baird and AGEN
- What is Robert W. Baird's price target for AGEN?
- Robert W. Baird's latest stated price target for Agenus Inc. (AGEN) is $8, from its action on Jul 19, 2024.
- What is Robert W. Baird's rating on AGEN?
- Robert W. Baird rates AGEN Neutral, a neutral rating, as of Jul 19, 2024.
- When did Robert W. Baird last change its view on AGEN?
- On Jul 19, 2024, Robert W. Baird downgrades to Neutral from Outperform, price target $35 to $8.
- How does Robert W. Baird's AGEN target compare with other analysts?
- Across 3 firms with a AGEN price target in the last 12 months, the median target is $30.
More AGEN rating histories
All Robert W. Baird ratingsAGEN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.